A team of Alzheimer’s disease (AD) researchers at Brigham and Women’s Hospital (BWH) has been able to study the underlying causes of AD and develop assays to test newer approaches to treatment by using stem cells derived from related family members with a genetic predisposition to (AD).
U.S. Senator Elizabeth Warren (D-MA) today addressed a national audience on the need to ensure equity for women in biomedical research. The Senator’s remarks were part of “Charting the Course: A National Policy Summit on the Future of Women’s Health,” held in Boston, hosted by Brigham and Women’s Hospital (BWH), and timed to celebrate and reflect on the 20th anniversary of the landmark National Institutes of Health (NIH) Revitalization Act that required NIH-funded medical research to include women and minorities.
Marathon Bombing Survivors Break Silence to Save Lives, Limbs
A Boston family affected by the Boston Marathon bombing tragedy is sharing their story in an effort to save lives and limbs. The Reny family emerged from tragedy with a selfless commitment to help others facing traumatic injuries with the creation of the Gillian Reny Stepping Strong Fund.
Researchers at BWH and Carnegie Mellon University Announce New Advance in 3D Printing and Tissue Engineering
Researchers at BWH and Carnegie Mellon University have introduced a unique micro-robotic technique to assemble the components of complex materials, the foundation of tissue engineering and 3D printing.
Researchers from Brigham and Women's Hospital (BWH) have found that exposure to short wavelength, or blue light, during the biological day directly and immediately improves alertness and performance. These findings are published in the February issue of Sleep.
Researchers from Brigham and Women's Hospital (BWH), in collaboration with the RIKEN Center for Developmental Biology in Japan, have demonstrated that any mature adult cell (a "somatic" cell) has the potential to turn into the equivalent of an embryonic stem cell.
A new study from researchers at Brigham and Women’s Hospital (BWH) shows that most cardiac implantable electronic devices (CIEDs) used by physicians today were approved as changes, or “supplements,” to existing PMA-approved models, often without the collection of new clinical data.
The Massachusetts Health Policy Commission voted on Dec. 18 to release its preliminary Cost and Market Impact Review (CMIR) of the proposed merger of South Shore Hospital with Partners and the BWPO’s proposed acquisition of Harbor Medical Group, with a 30-day public comment period to follow. Partners, BWH and SSH submitted a detailed response to that report to the HPC on Jan. 17. The HPC is expected to issue its final report later in February. Read the full report here.
Researchers at BWH have made a discovery that provides new insight into the body’s rejection process. Researchers have demonstrated that immune cells, or T cells, involved in the rejection process are significantly of donor origin.
In the preclinical study, researchers from Boston Children's Hospital, BWH and Massachusetts Institute of Technology (MIT) developed a bio-inspired adhesive that could rapidly attach biodegradable patches inside a beating heart-in the exact place where congenital holes in the heart occur, such as with ventricular heart defects.
In new findings from Brigham and Women's Hospital (BWH), researchers find that the most frequent reasons for readmission were often related, either directly or indirectly, to patients' underlying chronic medical conditions (comorbidities), providing a new opportunity for focus in reducing readmission rates.
Send Feedback to: BWH Media Relations
This page was last modified on 3/7/2014